Search research articles
Contact Us
Filters
Showing results (91-100 of 337) with videos related to
Page
of 34
Sort By:
Acta Neuropathologica Communications
|
March 2, 2016
Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles
Annett Hölsken, Martin Sill, Jessica Merkle, et al.
Neuro-Oncology
|
February 16, 2021
Integrated molecular analysis of adult sonic hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicator
Andrey Korshunov, Konstantin Okonechnikov, Damian Stichel, et al.
Journal of Neuro-Oncology
|
October 12, 2012
HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment
Till Milde, Marco Lodrini, Larissa Savelyeva, et al.
Brain Pathology (Zurich, Switzerland)
|
May 3, 2021
Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup
Francesca Zin, Jennifer A Cotter, Christine Haberler, et al.
Scientific Reports
|
April 19, 2017
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation
Emma Sandén, Cecilia Dyberg, Cecilia Krona, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2021
FOXR2 Stabilizes MYCN Protein and Identifies Non-<i>MYCN</i>-Amplified Neuroblastoma Patients With Unfavorable Outcome
Felix Schmitt-Hoffner, Sjoerd van Rijn, Umut H Toprak, et al.
Neuro-Oncology Advances
|
April 27, 2022
Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastoma
Sonja Krausert, Sebastian Brabetz, Norman L Mack, et al.
Acta Neuropathologica
|
April 29, 2019
Molecular progression of SHH-activated medulloblastomas
Andrey Korshunov, Konstantin Okonechnikov, Felix Sahm, et al.
Neuro-Oncology
|
September 26, 2018
DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas
Andrey Korshunov, Felix Sahm, Olga Zheludkova, et al.
Journal of Neuropathology and Experimental Neurology
|
February 8, 2006
OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas
Talitha de Haas, Esmeralda Oussoren, Wieslawa Grajkowska, et al.
Page
of 34
Search research articles
Search
Showing results (91-100 of 337) with videos related to
Sort By:
Page
of 34
Acta Neuropathologica Communications
|
March 2, 2016
Adamantinomatous and papillary craniopharyngiomas are characterized by distinct epigenomic as well as mutational and transcriptomic profiles
Annett Hölsken, Martin Sill, Jessica Merkle, et al.
Neuro-Oncology
|
February 16, 2021
Integrated molecular analysis of adult sonic hedgehog (SHH)-activated medulloblastomas reveals two clinically relevant tumor subsets with VEGFA as potent prognostic indicator
Andrey Korshunov, Konstantin Okonechnikov, Damian Stichel, et al.
Journal of Neuro-Oncology
|
October 12, 2012
HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment
Till Milde, Marco Lodrini, Larissa Savelyeva, et al.
Brain Pathology (Zurich, Switzerland)
|
May 3, 2021
Histopathological patterns in atypical teratoid/rhabdoid tumors are related to molecular subgroup
Francesca Zin, Jennifer A Cotter, Christine Haberler, et al.
Scientific Reports
|
April 19, 2017
Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation
Emma Sandén, Cecilia Dyberg, Cecilia Krona, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 10, 2021
FOXR2 Stabilizes MYCN Protein and Identifies Non-<i>MYCN</i>-Amplified Neuroblastoma Patients With Unfavorable Outcome
Felix Schmitt-Hoffner, Sjoerd van Rijn, Umut H Toprak, et al.
Neuro-Oncology Advances
|
April 27, 2022
Predictive modeling of resistance to SMO inhibition in a patient-derived orthotopic xenograft model of SHH medulloblastoma
Sonja Krausert, Sebastian Brabetz, Norman L Mack, et al.
Acta Neuropathologica
|
April 29, 2019
Molecular progression of SHH-activated medulloblastomas
Andrey Korshunov, Konstantin Okonechnikov, Felix Sahm, et al.
Neuro-Oncology
|
September 26, 2018
DNA methylation profiling is a method of choice for molecular verification of pediatric WNT-activated medulloblastomas
Andrey Korshunov, Felix Sahm, Olga Zheludkova, et al.
Journal of Neuropathology and Experimental Neurology
|
February 8, 2006
OTX1 and OTX2 expression correlates with the clinicopathologic classification of medulloblastomas
Talitha de Haas, Esmeralda Oussoren, Wieslawa Grajkowska, et al.
Page
of 34